32155989|t|A Unique GSK-3beta inhibitor B10 Has a Direct Effect on Abeta, Targets Tau and Metal Dyshomeostasis, and Promotes Neuronal Neurite Outgrowth.
32155989|a|Due to the complicated pathogenesis of Alzheimer's disease (AD), the development of multitargeted agents to simultaneously interfere with multiple pathological processes of AD is a potential choice. Glycogen synthase kinase-3beta (GSK-3beta) plays a vital role in the AD pathological process. In this study, we discovered a novel 1H-pyrrolo[2,3-b]pyridine derivative B10 as a GSK-3beta inhibitor that features with a quinolin-8-ol moiety to target the metal dyshomeostasis of AD. B10 potently inhibited GSK-3beta with an IC50 of 66 +- 2.5 nM. At the concentration of 20 muM, B10 increased beta-catenin abundance (beta-catenin/GAPDH: 0.83 +- 0.086 vs. 0.30 +- 0.016), phosphorylated GSK-3beta at Ser9 (p-GSK-3beta/GAPDH: 0.53 +- 0.045 vs. 0.35 +- 0.012), and decreased the phosphorylated tau level (p-tau/GAPDH: 0.33 +- 0.065 vs. 0.83 +- 0.061) in SH-SY5Y cells. Unlike other GSK-3beta inhibitors, B10 had a direct effect on Abeta by inhibiting Abeta1-42 aggregation and promoting the Abeta1-42 aggregate disassociation. It selectively chelated with Cu2+, Zn2+, Fe3+, and Al3+, and targeted AD metal dyshomeostasis. Moreover, B10 effectively increased the mRNA expression of the recognized neurogenesis markers, GAP43, N-myc, and MAP-2, and promoted the differentiated neuronal neurite outgrowth, possibly through the GSK-3beta and beta-catenin signal pathways. Therefore, B10 is a potent and unique GSK-3beta inhibitor that has a direct on Abeta and serves as a multifunctional anti-AD agent for further investigations.
32155989	9	18	GSK-3beta	Gene	2932
32155989	29	32	B10	Gene	5169
32155989	56	61	Abeta	Gene	351
32155989	71	74	Tau	Gene	4137
32155989	79	84	Metal	Chemical	MESH:D008670
32155989	181	200	Alzheimer's disease	Disease	MESH:D000544
32155989	202	204	AD	Disease	MESH:D000544
32155989	315	317	AD	Disease	MESH:D000544
32155989	341	371	Glycogen synthase kinase-3beta	Gene	2932
32155989	373	382	GSK-3beta	Gene	2932
32155989	410	412	AD	Disease	MESH:D000544
32155989	509	512	B10	Gene	5169
32155989	518	527	GSK-3beta	Gene	2932
32155989	559	572	quinolin-8-ol	Chemical	-
32155989	594	599	metal	Chemical	MESH:D008670
32155989	618	620	AD	Disease	MESH:D000544
32155989	622	625	B10	Gene	5169
32155989	645	654	GSK-3beta	Gene	2932
32155989	717	720	B10	Gene	5169
32155989	731	743	beta-catenin	Gene	1499
32155989	755	767	beta-catenin	Gene	1499
32155989	768	773	GAPDH	Gene	2597
32155989	824	833	GSK-3beta	Gene	2932
32155989	845	854	GSK-3beta	Gene	2932
32155989	855	860	GAPDH	Gene	2597
32155989	929	932	tau	Gene	4137
32155989	942	945	tau	Gene	4137
32155989	946	951	GAPDH	Gene	2597
32155989	989	996	SH-SY5Y	CellLine	CVCL:0019
32155989	1017	1026	GSK-3beta	Gene	2932
32155989	1039	1042	B10	Gene	5169
32155989	1066	1071	Abeta	Gene	351
32155989	1191	1195	Cu2+	Chemical	-
32155989	1197	1201	Zn2+	Chemical	-
32155989	1203	1207	Fe3+	Chemical	-
32155989	1213	1217	Al3+	Chemical	-
32155989	1232	1255	AD metal dyshomeostasis	Disease	MESH:D000544
32155989	1267	1270	B10	Gene	5169
32155989	1353	1358	GAP43	Gene	2596
32155989	1360	1365	N-myc	Gene	4613
32155989	1371	1376	MAP-2	Gene	4133
32155989	1459	1468	GSK-3beta	Gene	2932
32155989	1473	1485	beta-catenin	Gene	1499
32155989	1514	1517	B10	Gene	5169
32155989	1541	1550	GSK-3beta	Gene	2932
32155989	1582	1587	Abeta	Gene	351
32155989	1625	1627	AD	Disease	MESH:D000544
32155989	Positive_Correlation	2596	5169
32155989	Association	MESH:D000544	2932
32155989	Negative_Correlation	2932	5169
32155989	Association	2597	2932
32155989	Association	MESH:D008670	MESH:D000544
32155989	Association	351	5169
32155989	Positive_Correlation	4613	5169
32155989	Negative_Correlation	4137	5169
32155989	Positive_Correlation	4133	5169
32155989	Positive_Correlation	1499	5169
32155989	Association	MESH:D000544	5169

